A new era of metal-based drugs started in the 1960s, heralded by the discovery of potent
platinum-based complexes, commencing with cisplatin [(H3N) 2PtCl2], which are effective …

In recent years, both metal-based complexes and selenium-containing compounds have
been widely explored for their therapeutic properties due to their roles in biological …

Three platinum (II) complexes of dicyclopentadiene (DCP) and dithiocarbamates (DTCs),
namely,[Pt (η4-DCP)(Me2DTC)] PF6 (1),[Pt (η4-DCP)(Et2DTC)] PF6 (2), and [Pt (η4 …

Privileged structures have been widely used as effective templates for drug discovery. While
benzo‐1, 4‐diazepine constitutes the first historical example of such a structure, the 1, 3 …

Platinum (IV) complexes stabilized by N-heterocyclic carbene ligands of the type [(NHC)
PtX4L], where L is a neutral nitrogen-based ligand and X is a halide anion (Br, Cl), were …

The medicinal properties of transition metal complexes are greatly influenced by the nature
and physico-chemical features of the ligand present in the complex structure. Due to the …

Metal-based agents in cancer therapy, like cisplatin and its derivates, have established
clinical applications but also can induce serious side effects. Thus, metallotherapeutic …

Platinum (II) coordination compounds are widely applied in clinics as anticancer drugs. In
this review, we provide a summary of the reports on cytotoxic properties of platinum (II) …

Gold (I)-carbene complexes containing a selenone ligand (L),[Au (IPr)(L)] PF 6 {where, IPr=
1, 3-Bis (2, 6-di-isopropylphenyl) imidazol-2-ylidene and L= Ni-propyl-1, 3-imidazolidine-2 …

New bis (selone)‐based metal complexes,[MnLxCly]{M= Pd, L= 3, 3′‐[(2‐bromo‐1, 3‐
phenylene) bis (methylene)] bis (1‐mesityl‐1, 3‐dihydro‐2H‐imidazole‐2‐selone)(15), n= 2 …